Drug Profile
RW 94
Latest Information Update: 28 Aug 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Obesity therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 09 Mar 1999 New profile
- 09 Mar 1999 Investigation in Obesity in United Kingdom (PO)